Table 5 Response by tumor subtypes and treatment line
Characteristics | Partial response N (%) | P |
|---|---|---|
Triple negative | ||
Yes | 8 (30.7) | n.s. |
Not | 19 (21.8) | |
ER/PgR status | ||
ER and/or PgR positive 88 | 18 (20.5) | n.s. |
ER and/or PgR negative 30 | 9 (30) | |
HER2 | ||
Overexpressed/amplified | 4 (33.3) | n.s. |
Not overexpressed/amplified | 17 (18.2) | |
Dominant disease site | ||
Visceral | 22 (27.1) | n.s. |
Non visceral | 5 (15.6) | |
Number of metastatic disease | ||
1 | 3 (16.7) | n.s. |
≥2 | 24 (25.3) | |
Number of prior chemotherapy for advanced disease | ||
2 | 8 (30.7) | n.s. |
≥3 | 19 (21.8) |